UK markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.30+0.23 (+0.60%)
As of 01:10PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
148,643
57,242
175,688
45,009
-
Other short-term investments
489,439
534,845
376,086
131,988
-
Total cash
638,082
592,087
551,774
176,997
-
Net receivables
874
986
2,765
1,822
-
Other current assets
6,006
7,225
4,481
-
-
Total current assets
644,962
600,298
559,020
181,783
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
30,097
25,611
25,872
22,034
-
Accumulated depreciation
-11,251
-8,705
-13,350
-15,154
-
Net property, plant and equipment
18,846
16,906
12,522
6,880
-
Equity and other investments
292,792
128,682
0
-
-
Total non-current assets
319,836
153,848
12,987
7,403
-
Total assets
964,798
754,146
572,007
189,186
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
-
4,650
Accounts payable
8,598
8,491
3,824
3,041
-
Accrued liabilities
9,951
7,900
3,953
4,974
-
Deferred revenues
-
-
0
3,642
29,743
Total current liabilities
27,273
22,702
14,322
14,781
-
Non-current liabilities
Long-term debt
-
-
-
-
10,889
Deferred revenues
-
-
-
0
709
Total non-current liabilities
9,604
9,947
7,652
3,050
-
Total liabilities
36,877
32,649
21,974
17,831
-
Stockholders' equity
Common stock
1,436,374
1,065,136
790,902
405,480
-
Retained earnings
-665,140
-482,747
-357,374
-278,492
-
Accumulated other comprehensive income
-77
-3,000
-990
-990
-
Total stockholders' equity
927,921
721,497
550,033
171,355
-
Total liabilities and stockholders' equity
964,798
754,146
572,007
189,186
-